Skip to content

Evaluation trial on the effectiveness and safety of the Tolerance Repair Cream (TR cream) for rosacea

Evaluation trial on the effectiveness and safety of the Tolerance Repair Cream (TR cream) for rosacea

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124566
Enrollment
Unknown
Registered
2026-05-13
Start date
2023-05-31
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

Experimental group:The same subject applied the TR cream to the half of the face.
Control group:The other half of the same subject's face was treated with the TE cream.

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Those who voluntarily participate in this trial, have signed the informed consent form, and are able to use the trial products as required and complete the follow-up; 2. Chinese subjects aged between 18 and 60 years old; 3. Patients diagnosed with erythematotelangiectatic rosacea (ETR) in clinical terms; Those who meet all the above requirements can be included.

Exclusion criteria

Exclusion criteria: 1. Those with other inflammatory skin diseases or wounds on the face that make skin sampling inappropriate; 2. Those who have a known history of allergy to any component of the research product; 3. Those who are currently receiving medication that may interfere with the research results; 4. Those with severe systemic diseases, including tumors, bleeding tendencies and coagulation disorders, or those with concurrent liver, cardiovascular and other diseases, or those who have a history of thrombosis or cerebral ischemia; 5. Pregnant, potential pregnant or lactating women or those who have been postpartum for less than half a year; 6. Patients who are currently participating in other clinical studies or have participated in other clinical studies within the past 1 month; 7. Those who the researchers consider not suitable for inclusion; Any individuals meeting any of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
Skin current sensation threshold;Rosacea clinical scorecard;

Secondary

MeasureTime frame
Water content of stratum corneum;Transepidermal Water Loss;Skin color;Capsaicin pricking test;Lactic acid sting test;

Countries

China

Contacts

Public ContactWu Yan

Peking University First Hospital

3437477565@qq.com+86 157 2470 2521

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026